Cyclophil Me 100mg Capsule
Cyclophil Me 100mg Capsule is a trusted medication containing Cyclosporine, designed for personal use under the guidance of a healthcare professional. Available for prescription-based international supply with discreet worldwide delivery.
- Active ingredient: Cyclosporine
- Strength: 100 mg
- Form: Capsule
- Indication: Transplant rejection prophylaxis; severe rheumatoid arthritis; severe psoriasis; nephrotic syndrome
- Manufacturer: BIOCON LIMITED
This medicine is available to order. Contact us for current pricing and availability.
Request pricing for Cyclophil Me 100mg Capsule
Our support team will review your request and contact you within 24 hours with pricing and next steps.
Request sent!
What is Cyclosporine?
How Does It Work?
Cyclosporine binds the cytoplasmic protein cyclophilin A, forming a drug-protein complex inside T cells.
The cyclosporine-cyclophilin complex inhibits calcineurin, a phosphatase that normally activates NFAT transcription factors in T lymphocytes.
Without calcineurin activity, NFAT cannot enter the nucleus, so T cells fail to produce IL-2 and cannot proliferate in response to alloantigens — preventing rejection and autoimmune inflammation.
How to Use
- Transplant: 10–15 mg/kg/day initially in 2 divided doses; tapered to lowest effective trough-guided dose
- Neoral and Sandimmune are NOT bioequivalent — never switch formulations without therapeutic drug monitoring
- Take consistently with respect to food and time of day for stable blood levels
Take exactly as prescribed. Your prescriber's instructions replace the general guidance above.
Side Effects & Precautions
- Nephrotoxicity (dose-dependent)
- Hypertension
- Tremor
- Hirsutism
- Gingival hyperplasia
- Hyperkalaemia
- Chronic nephrotoxicity (cumulative kidney damage)
- Hypertension requiring antihypertensive treatment
- Lymphoma and skin malignancies
- Neurotoxicity (encephalopathy, seizures at high levels)
- Uncontrolled hypertension or active infections (non-transplant use)
- Concurrent potassium-sparing diuretics (hyperkalaemia risk)
- Concurrent nephrotoxic drugs without close monitoring
Generic vs Brand
Chitra Shetty is a licensed clinical pharmacist with 14 years of experience. She holds a B.Pharm and M.Pharm from Sambalpur University. At OnlineMeds, she reviews medicine and health content to help ensure it is accurate, evidence-based, and easy to understand.
Storage & Handling
Why Buy From Us
Sourced directly from licensed pharmaceutical manufacturers.
Sourced from licensed manufacturers through regulated supply channels.
Discreet shipping to UK, US, AU, EU and beyond.
Regulated and compliant with international pharmacy standards.
Frequently Asked Questions
Nephrotoxicity and hepatotoxicity — use only under supervision of physicians experienced in immunosuppressive therapy and organ transplant management.
Increased susceptibility to infection and lymphoma with concurrent immunosuppressants.
Drug Interactions
| Drug / Substance | Effect | Action |
|---|---|---|
| Nephrotoxic drugs (aminoglycosides, NSAIDs — additive kidney damage) | ||
| CYP3A4 inhibitors (ketoconazole, diltiazem — increase cyclosporine levels) | ||
| CYP3A4 inducers (rifampicin, carbamazepine — reduce levels) | ||
| Statins (increased myopathy risk) | ||
| Grapefruit juice (increases cyclosporine levels) | ||